Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2000
05/17/2000EP0804191B1 Use of inhibitors of platelet derived growth receptor for the manufacture of a medicament for the treatment of cancers
05/17/2000EP0753519B1 Hexaazaisowurtzitane derivatives and process for producing the same
05/17/2000CN1253561A Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5) for treatment of sexual dysfunction
05/17/2000CN1252988A Dye composition containing cationic direct dye and pyraole (1,5-alpha) pyradine as oxidative developing alkali and method of dyeing
05/17/2000CN1052484C 2,2' Disulfo (5-alkoxy [1,2,4] triazolo [1,5-c] pyrimidine) compounds and their use
05/17/2000CN1052483C Hexaazaisowurtzitane derivative and process for producing same
05/16/2000US6063924 N-(alkenyl or alkynyl)oxycarbonyl substituted chromophore derivatives; soluble organic pigments
05/16/2000US6063804 Pyrrole compounds
05/16/2000US6063803 Octahydropyrrolo-[3,4-c]carbazoles useful as analgesic agents
05/16/2000US6063782 Pyrrolopyridazine derivatives
05/16/2000US6063777 Iminochlorinaspartic acid derivatives
05/16/2000US6063774 Tricyclic quinoxaline derivatives as neuroprotective agents
05/16/2000US6063361 Administering to a patient at least one cascade polymer complex and subjecting the patient to a radiology diagnosis
05/16/2000CA2180263C Diazabicyclic neurokinin antagonists
05/16/2000CA2011658C New 1,7-annelated 1h-indole-2-carboxylic acid-n-(1,4-benzodiazepin-3-yl) amides
05/11/2000WO2000026643A1 Method for non-invasive imaging oxygen distribution in multi-dimensions and apparatus therefor
05/11/2000WO2000026218A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors
05/11/2000WO2000018381A8 Use of epinastine as antitussivum
05/11/2000WO2000013015A8 Modulating multiple lineage kinase proteins
05/11/2000CA2348527A1 Method for non-invasive imaging oxygen distribution in multi-dimensions and apparatus therefor
05/11/2000CA2345337A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors
05/10/2000EP0998908A2 Dyeing composition containing a cattonic and an oxidativ dye based an pyrazolo-(1,5)-pyramidine and dyeing process
05/10/2000EP0998476A1 1,4,7,10-tetraazabicyclo 8.2.2]tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles
05/10/2000EP0998475A1 Novel compounds
05/10/2000EP0998466A1 A process for the preparation of tetraazamacrocycles
05/10/2000EP0998285A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
05/10/2000EP0741710B1 Chloropyrimidine intermediates
05/10/2000CN1052233C Alkaloids from mappia foetida, the use and formulations containing them
05/09/2000US6060608 Analogs of CC-1065 and the duocarmycins
05/09/2000US6060598 Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding
05/09/2000US6060478 Azolo triazines and pyrimidines
05/09/2000US6060467 Graft survival prolongation with porphyrins
05/09/2000US6060432 Synergistic mixture; crops, agriculture
05/04/2000WO2000024745A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
05/04/2000WO2000024744A1 Bicyclic nitrogen heterocycles
05/04/2000WO2000024741A2 Dihydropyridine compounds and their use as potassium channel openers
05/04/2000WO1999064038A9 Novel analgesic agents
05/04/2000WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS
05/04/2000WO1999063988A9 Inhibitors of nitric oxide synthase
05/04/2000CA2348165A1 Dihydropyridine compounds and methods of use
05/04/2000CA2288253A1 Formulation for a dye containing a direct cationic dye and a pyrazolo-[1,5-a -pyrimidine as an oxydation base, and dying processes that utilize the formulation
05/03/2000EP0997466A1 Novel antimicrobial lactam-quinolones
05/03/2000EP0997153A1 Formulations for lipophilic compounds
05/03/2000EP0996621A1 Novel compounds
05/03/2000EP0996620A1 Novel compounds
05/03/2000EP0996447A1 Combination therapy for modulating the human sexual response
05/03/2000EP0678094B1 2-alkoxy-4-hydrazinopyrimidine compounds and their use in the preparation of 5-alkoxy[1,2,4]triazolo[4,3-c]pyrimidine-3(2h)-thione compounds
05/03/2000CN1252085A Fluorescent compositions and their use
05/03/2000CN1252084A Fluorescent compositions and preparation and use thereof
05/02/2000US6057457 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
05/02/2000US6057454 1-oxo-1H-inden-2-yl-1H-imidazole-2-carboxylic acid intermediates
05/02/2000US6057449 Direct preparation of pyrrolo[3,4-c]pyrroles
05/02/2000US6057445 Formation of carbon nitrogen bond, cyclization and halogenation
05/02/2000US6057440 Process for preparing bis-indoly macrocycles
05/02/2000US6057336 Lactam metalloprotease inhibitors
05/02/2000US6057335 Treatment of bulimia, obesity or diabetes
05/02/2000US6057330 Pyrrolopyrazolopyrimidine compound and medicine comprising the same as active ingredient
05/02/2000US6057321 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application
05/02/2000US6057315 Antibacterial agents
05/02/2000US6057314 Anticoagulants
05/02/2000US6057120 Quantitative or qualitative detection of analyte by contacting sample with indicator and detecting change in property of reagent; reagent is stable in reduced and oxidized forms
04/2000
04/27/2000WO2000023487A1 Amino-ketone solid support templates
04/27/2000WO2000023450A1 Fused pyridazine derivatives, process for the preparation of the same and uses thereof
04/27/2000WO2000023449A1 Pyrazolo-triazine derivatives as ligands for gaba receptors
04/27/2000WO2000023446A1 Core-extended perylene bisimides and the use thereof as fluorescent dyes
04/27/2000WO2000023424A1 Epibatidine analogues as acetylcholine receptor antagonists
04/27/2000WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors
04/27/2000DE19848555A1 New perylene-3,4,9,10-tetracarboxylic acid bis-imide derivatives and analogs, used as dyes, especially fluorescent dyes, e.g. for bulk dyeing plastics, vat dyeing natural fibers or staining DNA
04/27/2000CA2348022A1 Condensed pyridazine derivatives, their production and use
04/27/2000CA2347243A1 Amino-ketone solid support templates
04/27/2000CA2346289A1 Pyrazolo-triazine derivatives as ligands for gaba receptors
04/26/2000EP0995755A1 Prodrugs of Thrombin inhibitors
04/26/2000EP0995751A2 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
04/26/2000EP0995750A1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
04/26/2000EP0995748A1 Growth hormone secretagogues
04/26/2000EP0995742A1 Sulfonamide compounds and medicinal use thereof
04/26/2000EP0994878A1 Quinolone carboxylic acid derivatives
04/26/2000EP0994877A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
04/26/2000EP0994875A1 3-pyridyl-1-aza-bicyclo-alkane derivatives for prevention and treatment of cns disorders
04/26/2000EP0994862A2 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
04/26/2000EP0994860A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists
04/26/2000EP0994708A1 Antagonists of gonadotropin releasing hormone
04/26/2000EP0777671B1 Spiro-azabicyclic compounds useful in therapy
04/26/2000EP0579802B1 Bicycle-polyazamacrocyclocarboxylic acid complexes, conjugates, preparation and use as contrast agents
04/26/2000CN1251606A Fluorescent chromophore covalently linked to organic support material
04/26/2000CN1251589A Substituted triazolo-pyridazine derivatives as ligands for GABA receptors
04/26/2000CN1251312A Stable complex of insoluble chemical compound
04/25/2000US6054464 Azabicyclic esters of carbamic acids useful in therapy
04/25/2000US6054460 Anticonvulsive and antiallergic/antiasthmatic pyrazolo-[3,4-d]pyrimidines, and process for preparing
04/25/2000US6054459 Insecticides and ectoparasiticides
04/25/2000US6054449 Photodynamic therapy
04/23/2000CA2287562A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
04/21/2000CA2287122A1 Treatment of bph with cgmp elevators
04/20/2000WO2000022079A1 Detergent compositions or components
04/20/2000WO2000021965A1 Substituted perhalogenated phthalocyanines
04/20/2000WO2000021964A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and anfiinflammatory activity
04/20/2000WO2000021959A1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use
04/20/2000WO2000021926A2 6-SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS
04/20/2000WO2000021920A1 Diaminopropionic acid derivatives
04/20/2000WO1999064050A9 Novel potassium channel drugs and their uses